日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

In silico molecular docking and ADMET prediction of biogenic zinc oxide nanoparticles: characterization, and in vitro antimicrobial and photocatalytic activity

利用计算机分子对接和ADMET预测生物源氧化锌纳米粒子：表征、体外抗菌和光催化活性

期刊:RSC Advances
影响因子:4.6
doi:10.1039/d4ra06890d
Akhter, Hajara; Ritu, Susmita Sarker; Siddique, Shahariar; Chowdhury, Fariha; Chowdhury, Rehnuma Tasmiyah; Akhter, Samina; Hakim, Mahmuda
MET
发表日期：2024
文献求助 收藏

The efficacy and safety of the novel combination lenvatinib and pembrolizumab in endometrial cancer: A systematic review and single-arm meta-analysis

新型联合疗法乐伐替尼和帕博利珠单抗治疗子宫内膜癌的疗效和安全性：系统评价和单臂荟萃分析

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e30257
Sultan, Wania; Siddiqui, Tasmiyah; Mughal, Sanila; Sultan, Ayman; Pandey, Shubram; Ali Baig, Mirza Mehmood
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes - a review

结直肠癌治疗创新：三氟尿苷和替吡嘧啶联合贝伐单抗可改善疗效——综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1296765
Rais, Taruba; Riaz, Rumaisa; Siddiqui, Tasmiyah; Shakeel, Amna; Khan, Afsheen; Zafar, Habiba
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Acetylsalicylic acid dosed at bedtime vs. dosed in the morning for circadian rhythm of blood pressure- a systematic review and meta-analysis

睡前服用乙酰水杨酸与早晨服用乙酰水杨酸对血压昼夜节律的影响——系统评价和荟萃分析

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2024.1346265
Nadeem, Abdullah; Rais, Taruba; Aamir, Minahil; Habte, Alexander; Siddiqui, Tasmiyah; Karamat, Riyan Imtiaz; Munsab, Rabbia; Habib, Ashna
发表日期：2024
文献求助 收藏

Comparing surgical outcomes: Craniotomy versus decompressive craniectomy in acute subdural hematoma - A systematic review and meta-analysis

比较手术结果：开颅手术与减压性颅骨切除术治疗急性硬膜下血肿——系统评价和荟萃分析

期刊:World Neurosurgery: X
影响因子:2
doi:10.1016/j.wnsx.2024.100368
Nadeem, Abdullah; Siddiqui, Tasmiyah; Rais, Taruba; Munsab, Rabbia; Habib, Ashna; Afridi, Eesha Khan; Shariq, Fariha
发表日期：2024
文献求助 收藏

Japanese encephlu emergence in Australia: the potential population at risk

日本脑炎病毒在澳大利亚的出现：潜在风险人群

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1097/MS9.0000000000001739
Khan, Afsheen; Riaz, Rumaisa; Nadeem, Abdullah; Amir, Ayesha; Siddiqui, Tasmiyah; Batool, Um E A; Raufi, Nahid
微生物学
脑炎
神经科学
发表日期：2024
文献求助 收藏

Novel breakthrough in the treatment of sphingomyelinase deficiency

鞘磷脂酶缺乏症治疗领域的新突破

期刊:International Journal of Surgery
影响因子:10.1
doi:10.1097/JS9.0000000000000102
Sultan, Wania; Siddiqui, Tasmiyah
发表日期：2023
文献求助 收藏

"Efficacy and safety of oteseconazole in recurrent vulvovaginal candidiasis (RVVC) - A systematic review and meta-analysis"

“奥替康唑治疗复发性外阴阴道念珠菌病（RVVC）的疗效和安全性——系统评价和荟萃分析”

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e20495
Siddiqui, Tasmiyah; Kumar, Kanwal Ashok; Iqbal, Amna; Doultani, Payal Rani; Ashraf, Tayyaba; Eqbal, Farea; Siddiqui, Samrah Inam
发表日期：2023
文献求助 收藏

Epcoritamab-bysp (Epkinly) - A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma

Epcoritamab-bysp（Epkinly）——弥漫性大B细胞淋巴瘤治疗领域的一项重大突破

期刊:Rare Tumors
影响因子:0.9
doi:10.1177/20363613231193566
Riaz, Rumaisa; Khan, Afsheen; Siddiqui, Tasmiyah
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2023
文献求助 收藏

Enhertu (Fam-trastuzumab-deruxtecan-nxki) - Revolutionizing treatment paradigm for HER2-Low breast cancer

Enhertu（Fam-trastuzumab-deruxtecan-nxki）——革新 HER2 低表达乳腺癌的治疗模式

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1016/j.amsu.2022.104665
Siddiqui, Tasmiyah; Rani, Payal; Ashraf, Tayyaba; Ellahi, Aayat
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏